Squarepoint Ops LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 78 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$515,797
-70.9%
19,196
-61.4%
0.00%
-80.0%
Q2 2023$1,773,514
-63.8%
49,734
-74.2%
0.01%
-75.0%
Q1 2023$4,894,224
+1843.4%
192,686
+3003.3%
0.02%
+1900.0%
Q4 2022$251,837
+5.4%
6,209
-14.0%
0.00%0.0%
Q3 2022$239,000
-95.0%
7,223
-94.7%
0.00%
-96.3%
Q2 2022$4,799,000
+427.4%
136,295
+588.6%
0.03%
+575.0%
Q1 2022$910,000
+109.2%
19,793
+184.3%
0.00%
+300.0%
Q3 2021$435,000
-15.7%
6,961
+11.8%
0.00%
-50.0%
Q2 2021$516,000
-43.3%
6,229
-70.5%
0.00%
-83.3%
Q3 2020$910,000
-16.0%
21,134
-15.7%
0.01%
-33.3%
Q2 2020$1,083,000
-44.7%
25,072
-63.1%
0.02%
-64.0%
Q1 2020$1,957,000
+353.0%
68,020
+898.7%
0.05%
+1566.7%
Q4 2019$432,000
+14.6%
6,811
-49.1%
0.00%0.0%
Q3 2019$377,000
-36.9%
13,385
-40.5%
0.00%
-50.0%
Q2 2019$597,000
-64.1%
22,510
-75.2%
0.01%
-66.7%
Q1 2019$1,664,000
+740.4%
90,654
+468.4%
0.02%
+800.0%
Q4 2018$198,000
+5.3%
15,949
-68.8%
0.00%
-33.3%
Q4 2017$188,000
+164.8%
51,200
+212.2%
0.00%
+200.0%
Q3 2017$71,000
+44.9%
16,400
-46.0%
0.00%0.0%
Q2 2017$49,000
+63.3%
30,398
+57.2%
0.00%0.0%
Q4 2016$30,00019,3400.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders